Cannabis Portfolio Growth Leverage MedReleaf Australia and Aurora Cannabis collaboration to target GP and pharmacist channels with expanded cannabis product lines, including premium dried flower and higher-THC options, to meet growing demand in Australia and New Zealand.

R&D Driven Highlight ongoing R&D emphasis to position as a partner for new product development, clinically supported formulations, and pipeline collaboration opportunities with healthcare providers seeking evidence-based cannabis therapies.

Compliance & Access Capitalize on MedReleaf’s concession schemes and regulated product launches to pursue government and institutional procurement, patient access programs, and physician education partnerships that expand distribution.

Sustainability Focus Promote environmental initiatives such as plastic waste offsets with CleanHub to align with buyers prioritizing sustainability, offering co-branded ESG storytelling for healthcare partners.

Strategic Partnerships Explore cross-sell opportunities with allied healthcare suppliers, clinics, and pharmacies by combining cannabis product introductions with support services, training, and streamlined supply via Sage X3 and related tech stack.